The Group's principal activities are to develop, manufacture and market generic and brand pharmaceutical products. The Group operates through three segments: Branded, Generic and Distribution. The Branded segment serves the specialty markets in urology and nephrology. The Generic pharmaceutical products segment includes off-patent pharmaceutical products that are therapeutically equivalent to proprietary products. Distribution Segment consists of Anda, Anda Pharmaceuticals and Valmed. The Group markets their products to pharmaceutical wholesalers, drug distributors and chain drug stores.
Alacra Alerts:
Receive alerts on the latest reports on Watson Pharmaceuticals, Inc.
Subscribe to Alacra Alerts via RSS and never miss the latest research on your favorite companies. Just click the images above to add the feed directly to your favorite newsreader.
